TY - JOUR
T1 - Ultrasound Evaluation of the Axilla in the Breast Imaging Setting
AU - Teichgraeber, Davis C.
AU - Perez, Frances
AU - Guirguis, Mary S.
AU - Kapoor, Megha M.
AU - Whitman, Gary J.
N1 - Publisher Copyright:
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2021/1/13
Y1 - 2021/1/13
N2 - ABSTRACT: Ultrasound evaluation of the axilla plays a critical role in the setting of newly diagnosed breast cancer as surgical management evolves toward more targeted axillary nodal resection. Regional nodal involvement by metastatic carcinoma is one of most important prognostic factors in breast cancer and guides local, regional, and systemic treatment. Ultrasound also evaluates response to neoadjuvant chemotherapy. This article will review ultrasound techniques and the anatomy and the morphology of axillary lymph nodes. Lymph node staging in breast cancer will also be discussed. Ultrasound-guided interventions and localizations and emerging technologies of elastography and contrast-enhanced ultrasound will be discussed. In addition, this article will discuss the role of ultrasound as it applies to management of the axilla since the American College of Surgeons Oncology Group Z011 and Z1071 trials. Finally, other causes of benign and malignant axillary lymphadenopathy, not related to breast cancer, are discussed.
AB - ABSTRACT: Ultrasound evaluation of the axilla plays a critical role in the setting of newly diagnosed breast cancer as surgical management evolves toward more targeted axillary nodal resection. Regional nodal involvement by metastatic carcinoma is one of most important prognostic factors in breast cancer and guides local, regional, and systemic treatment. Ultrasound also evaluates response to neoadjuvant chemotherapy. This article will review ultrasound techniques and the anatomy and the morphology of axillary lymph nodes. Lymph node staging in breast cancer will also be discussed. Ultrasound-guided interventions and localizations and emerging technologies of elastography and contrast-enhanced ultrasound will be discussed. In addition, this article will discuss the role of ultrasound as it applies to management of the axilla since the American College of Surgeons Oncology Group Z011 and Z1071 trials. Finally, other causes of benign and malignant axillary lymphadenopathy, not related to breast cancer, are discussed.
UR - http://www.scopus.com/inward/record.url?scp=85102609161&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102609161&partnerID=8YFLogxK
U2 - 10.1097/RUQ.0000000000000546
DO - 10.1097/RUQ.0000000000000546
M3 - Article
C2 - 33464028
AN - SCOPUS:85102609161
SN - 0894-8771
VL - 37
SP - 43
EP - 51
JO - Ultrasound Quarterly
JF - Ultrasound Quarterly
IS - 1
ER -